(6R)-6-Cyclopentyl-6-[2-(2,6-diethyl-4-pyridinyl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-5,6-dihydro-4-h ydroxy-2H-pyran-2-one

CAS: 877130-28-4

Ref. 3D-FC152905

Información del producto

• Nombre: (6R)-6-Cyclopentyl-6-[2-(2,6-diethyl-4-pyridinyl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-5,6-dihydro-4-h ydroxy-2H-pyran-2-one
• Sinónimos: (6R)-6-Cyclopentyl-6-[2-(2,6-diethyl-4-pyridinyl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-5,6-dihydro-4-hydroxy-2H-pyran-2-one, PF 00868554, Filibuvir, 2H-Pyran-2-one, 6-cyclopentyl-6-[2-(2,6-diethyl-4-pyridinyl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-5,6-dihydro-4-hydroxy-, (6R)-, (R)-6-Cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-[(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-one

Descripción

Fidovirsen is a nucleoside analogue that is an inhibitor of the NS3 protease of hepatitis C virus (HCV). Fidovirsen binds to the active site of the NS3 protease and prevents cleavage at the NS3/4A interface, thus inhibiting viral replication. It has been shown to be effective in clinical studies involving human liver samples. Fidovirsen has also been shown to have antiviral activity against other RNA viruses, including HIV-1 and influenza A virus. Fidovirsen has a low toxicity profile and does not exhibit cross-resistance with other antiviral drugs. The drug is being developed as a potential therapy for chronic HCV infection.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 503.64 g/mol
• Fórmula: C₂₉H₃₇N₅O₃
• Pureza: Min. 95%